Evidence map›Paper›PMID 33489686›Full record

Article3 Biotech2021

Improvement in the catalytic performance of a phenylpyruvate reductase from

Dong Zhang, Xiuxiu Zhu, Die Hu, Zheng Wen, Chen Zhang, Minchen Wu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in 3 Biotech, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Virtual Evolution of HVEM Segment for Checkpoint Inhibitor Discovery.International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dong Zhang *Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122 China.
Xiuxiu Zhu *School of Pharmaceutical Science, Jiangnan University, Wuxi, 214122 China.
Die HuWuxi School of Medicine, Jiangnan University, Wuxi, 214122 China.
Zheng WenKey Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122 China.
Chen ZhangSchool of Pharmaceutical Science, Jiangnan University, Wuxi, 214122 China.
Minchen WuWuxi School of Medicine, Jiangnan University, Wuxi, 214122 China.ORCID 0000-0003-2833-8436
Jiangnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To enhance the specific activity and catalytic efficiency ( SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13205-020-02633-3) contains supplementary material, which is available to authorized users.

Indexed as

Asymmetric reductionCatalytic performanceComputer-aided designLactobacillus plantarumMutagenesisPhenylpyruvate reductase

Identifiers

PMID33489686
PMCPMC7806690
OpenAlexW3120517849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.